hero-line-left hero-line-top
Life Sciences

Bringing precision medicine to more patients

Our life sciences partners are helping us answer tough questions about complex issues in cancer care.



Amgen and Syapse are creating opportunities for physicians and researchers within the Syapse Network to gain access to analytics, real-world evidence-based insights, and collaborative research opportunities. Amgen will also work with Syapse to develop real-world evidence standards to support the acceleration of therapies to market.


Pfizer and Syapse are working together to understand precision oncology treatment journeys and outcomes, and are gaining insights into molecular testing and therapy choices in the healthcare system setting.

What's new

Syapse Appoints Dr. Thomas D. Brown as Chief Medical Officer

SAN FRANCISCO – October 16, 2019 – Syapse today announced the appointment of Thomas D. Brown, MD, MBA as its first Chief Medical Officer. Dr…



Precision Medicine Goes Mainstream at Leading Health Systems

Precision medicine (or personalized medicine) has been a buzzword in the healthcare industry for many years. Depending on the audience, its…